Published in Synapse on June 01, 1995
The 5-HT3B subunit is a major determinant of serotonin-receptor function. Nature (1999) 2.91
Effects of moderate alcohol consumption on the central nervous system. Alcohol Clin Exp Res (1998) 2.60
Appetite suppression and weight loss after the cannabinoid antagonist SR 141716. Life Sci (1998) 2.12
Low doses of ethanol activate dopaminergic neurons in the ventral tegmental area. Brain Res (1985) 2.11
Microdialysis measurement of cortical and hippocampal acetylcholine release during sleep-wake cycle in freely moving cats. Brain Res (1995) 1.90
Free tryptophan in serum controls brain tryptophan level and serotonin synthesis. Life Sci II (1973) 1.80
Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats. Eur J Pharmacol (1992) 1.63
The role of dopamine in the mechanism of action of antidepressant drugs. Eur J Pharmacol (2000) 1.60
Predilution haemofiltration--the Second Sardinian Multicentre Study: comparisons between haemofiltration and haemodialysis during identical Kt/V and session times in a long-term cross-over study. Nephrol Dial Transplant (2001) 1.57
Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors. Eur J Pharmacol (1998) 1.53
Selective increase of brain dopamine induced by gamma-hydroxybutyrate: study of the mechanism of action. J Neurochem (1968) 1.51
Profound decrement of mesolimbic dopaminergic neuronal activity during ethanol withdrawal syndrome in rats: electrophysiological and biochemical evidence. Proc Natl Acad Sci U S A (1993) 1.50
Dose-dependent absorption and elimination of gamma-hydroxybutyric acid in healthy volunteers. Eur J Clin Pharmacol (1993) 1.47
Neonatal diabetes and DQB1 typing. Diabetes Care (1996) 1.43
Ethanol stimulates the firing rate of nigral dopaminergic neurons in unanesthetized rats. Brain Res (1984) 1.43
Buprenorphine: a controlled clinical trial in the treatment of opioid dependence. Drug Alcohol Depend (2000) 1.41
[Cost of ICU in Italy. Results from an empirical study on a sample of 12 hospitals]. Minerva Anestesiol (2001) 1.40
Stimulation of serotonin synthesis by lithium. J Pharmacol Exp Ther (1971) 1.40
Ability of baclofen in reducing alcohol craving and intake: II--Preliminary clinical evidence. Alcohol Clin Exp Res (2000) 1.38
Course of the manic-depressive cycle and changes caused by treatment. Pharmakopsychiatr Neuropsychopharmakol (1980) 1.36
Low androgenization index in elderly women and elderly men with Alzheimer's disease. Neurology (2004) 1.34
Ethanol markedly increases "GABAergic" neurosteroids in alcohol-preferring rats. Eur J Pharmacol (1999) 1.32
Dopaminergic correlates of motivated behavior: importance of drive. J Neurosci (1995) 1.29
Compulsive sexual activity induced by p-chlorophenylalanine in normal and pinealectomized male rats. Science (1969) 1.28
The role of stress in the pathophysiology of the dopaminergic system. Mol Psychiatry (2000) 1.26
Preferential stimulation of ventral tegmental area dopaminergic neurons by nicotine. Eur J Pharmacol (1987) 1.26
Central functions of oxytocin. Neurosci Biobehav Rev (1991) 1.26
Rapid depletion of serum tryptophan, brain tryptophan, serotonin and 5-hydroxyindoleacetic acid by a tryptophan-free diet. Life Sci (1974) 1.26
Reduction of voluntary ethanol intake in ethanol-preferring sP rats by the cannabinoid antagonist SR-141716. Alcohol Alcohol (1998) 1.23
Therapeutic efficacy of apomorphine combined with an extracerebral inhibitor of dopamine receptors in Parkinson's disease. Lancet (1979) 1.23
Impaired decision-making in opiate-dependent subjects: effect of pharmacological therapies. Drug Alcohol Depend (2005) 1.22
Sardinian alcohol-preferring rats: a genetic animal model of anxiety. Physiol Behav (1995) 1.21
Ability of baclofen in reducing alcohol intake and withdrawal severity: I--Preclinical evidence. Alcohol Clin Exp Res (2000) 1.20
Mesolimbic dopaminergic decline after cannabinoid withdrawal. Proc Natl Acad Sci U S A (1998) 1.20
Self-administration of the cannabinoid receptor agonist WIN 55,212-2 in drug-naive mice. Neuroscience (1998) 1.18
Effect of psychotropic drugs on tryptophan concentration in the rat brain. J Pharmacol Exp Ther (1971) 1.18
Essential role of testosterone in the sexual stimulation induced by p-chlorophenylalanine in male animals. Nature (1970) 1.17
Disulfiram and diethyldithiocarbamate intoxication affects the storage and release of striatal dopamine. Toxicol Appl Pharmacol (1996) 1.17
Profound decrease of mesolimbic dopaminergic neuronal activity in morphine withdrawn rats. J Pharmacol Exp Ther (1995) 1.17
A randomised control study comparing the Infant Flow Driver with nasal continuous positive airway pressure in preterm infants. Arch Dis Child Fetal Neonatal Ed (2001) 1.17
Role of GABA(B) receptors in the sedative/hypnotic effect of gamma-hydroxybutyric acid. Eur J Pharmacol (2001) 1.15
Self-inhibitory dopamine receptors: their role in the biochemical and behavioral effects of low doses of apomorphine. Adv Biochem Psychopharmacol (1978) 1.12
Activation of olfactory cortex in newborn infants after odor stimulation: a functional near-infrared spectroscopy study. Pediatr Res (2000) 1.12
Muscular weakness in the mdx mouse. J Neurol Sci (1993) 1.11
Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome. Lancet (1989) 1.11
Gamma-hydroxybutyric acid in the treatment of alcohol and heroin dependence. Alcohol (2000) 1.11
Localized epileptiform activity induced by murine CRF in rats. Epilepsia (1988) 1.10
The interaction of general anaesthetics and neurosteroids with GABA(A) and glycine receptors. Neurochem Int (1999) 1.09
Effect of the oral administration of tryptophan-free amino acid mixtures on serum tryptophan, brain tryptophan and serotonin metabolism. J Neurochem (1974) 1.06
[Fibrochondrogenesis]. Arch Fr Pediatr (1978) 1.06
Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex. Mol Psychiatry (2001) 1.05
Cannabinoid modulation of intestinal propulsion in mice. Eur J Pharmacol (1998) 1.05
CAD (computed-aided detection) and CADx (computer aided diagnosis) systems in identifying and characterising lung nodules on chest CT: overview of research, developments and new prospects. Radiol Med (2010) 1.05
History of the 'geste antagoniste' sign in cervical dystonia. J Neurol (2012) 1.04
Anti-inflammatory activity of linalool and linalyl acetate constituents of essential oils. Phytomedicine (2002) 1.04
Pharmacokinetics of gamma-hydroxybutyric acid in alcohol dependent patients after single and repeated oral doses. Br J Clin Pharmacol (1992) 1.03
Evidence for dopamine receptors mediating sedation in the mouse brain. Nature (1976) 1.02
Acetaldehyde mediates alcohol activation of the mesolimbic dopamine system. Eur J Neurosci (2007) 1.02
Association between dopamine receptor genes and migraine without aura in a Sardinian sample. Neurology (1998) 1.01
Increase in meso-prefrontal dopaminergic activity after stimulation of CB1 receptors by cannabinoids. Eur J Neurosci (1998) 1.01
Alcohol stimulates motor activity in selectively bred Sardinian alcohol-preferring (sP), but not in Sardinian alcohol-nonpreferring (sNP), rats. Alcohol (2001) 1.01
Antidepressant-like effect of ethanol revealed in the forced swimming test in Sardinian alcohol-preferring rats. Psychopharmacology (Berl) (1999) 1.01
Entrapment of the suprascapular nerve at the spinoglenoid notch. Ann Neurol (1982) 1.00
Elevated S100 blood level as an early indicator of intraventricular hemorrhage in preterm infants. Correlation with cerebral Doppler velocimetry. J Neurol Sci (1999) 1.00
Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum. Mol Pharmacol (1985) 1.00
The effect of a transmembrane amino acid on etomidate sensitivity of an invertebrate GABA receptor. Br J Pharmacol (1998) 0.99
Mesolimbic dopaminergic reduction outlasts ethanol withdrawal syndrome: evidence of protracted abstinence. Neuroscience (1996) 0.98
Dramatic depletion of mesolimbic extracellular dopamine after withdrawal from morphine, alcohol or cocaine: a common neurochemical substrate for drug dependence. Ann N Y Acad Sci (1992) 0.98
The human eye expresses high levels of CB1 cannabinoid receptor mRNA and protein. Eur J Neurosci (2000) 0.98
Oxytocin-induced penile erection and yawning: site of action in the brain. Brain Res (1986) 0.97
Laparoscopic extraperitoneal colostomy in elective abdominoperineal resection for cancer: a single surgeon experience. Colorectal Dis (2012) 0.97
The oxytocin antagonist d(CH2)5Tyr(Me)-Orn8-vasotocin inhibits male copulatory behaviour in rats. Eur J Pharmacol (1988) 0.97
Motor neuron disease in the province of Ferrara, Italy, in 1964-1982. Neurology (1988) 0.97
General anaesthetic action at transmitter-gated inhibitory amino acid receptors. Trends Pharmacol Sci (1999) 0.97
[The femoral hernia: problems in emergency surgery]. G Chir (2006) 0.97
Metoclopramide and dystonic reactions in Sardinians. Lancet (1979) 0.96
Apomorphine-induced penile erection and yawning: site of action in brain. Brain Res (1987) 0.96
Alcohol withdrawal in rats is associated with a marked fall in extraneuronal dopamine. Alcohol Clin Exp Res (1992) 0.96
Cannabinoid receptor CB1 mRNA is highly expressed in the rat ciliary body: implications for the antiglaucoma properties of marihuana. Brain Res Mol Brain Res (1998) 0.96
Increase of brain tryptophan and stimulation of serotonin synthesis by salicylate. J Neurochem (1973) 0.95
The diagnostic value of H-index in S1 root compression. J Neurol Neurosurg Psychiatry (1981) 0.95
A MERRF/MELAS overlap syndrome associated with a new point mutation in the mitochondrial DNA tRNA(Lys) gene. Eur J Hum Genet (1993) 0.95
Cerebral hemodynamic response to unpleasant odors in the preterm newborn measured by near-infrared spectroscopy. Pediatr Res (2001) 0.95
Evidence for a GABAergic projection from the substantia nigra to the ventromedial thalamus and to the superior colliculus of the rat. Brain Res (1979) 0.94
Dynamic aspects of neurohormonal control of cyclic 3',5'-AMP synthesis in brain. Adv Biochem Psychopharmacol (1970) 0.94
Biochemical and electrophysiologic evidence that propofol enhances GABAergic transmission in the rat brain. Anesthesiology (1991) 0.94
Multimodal imaging in the congenital pulmonary lymphangiectasia-congenital chylothorax-hydrops fetalis continuum. Lymphology (2004) 0.94
The cannabinoid receptor antagonist SR 141716 prevents acquisition of drinking behavior in alcohol-preferring rats. Eur J Pharmacol (2001) 0.94
Circadian drinking pattern of Sardinian alcohol-preferring rats. Alcohol Alcohol (1996) 0.93
The cannabinoid receptor agonist WIN 55,212-2 regulates glutamate transmission in rat cerebral cortex: an in vivo and in vitro study. Cereb Cortex (2001) 0.93
Increase of brain tryptophan caused by drugs which stimulate serotonin synthesis. Nat New Biol (1971) 0.93